IFM-514-treated NASH ApoE-/- mice had similar circulating IL-1β and IL-1α as vehicle-treated NASH ApoE-/- mice (Supplementary Figures 2D–E). The gene discussed is APOE; the disease is metabolic dysfunction-associated steatohepatitis.